Verastem Inc.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Frequently asked questions
To buy Verastem Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Verastem Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Verastem Inc. is VSTM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Verastem Inc. has its primary listing on NASDAQ. You can trade Verastem Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Verastem Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Verastem Inc. as part of a broader investment portfolio.